ARFAN QURESHI: Open Payments
NPI 1750816831 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 12 payments from 8 companies in 2025. Trend: 2023 $814 · 2024 $1,277 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $158 |
| Saluda Medical Americas, Inc. | 2 | $152 |
| AstraZeneca Pharmaceuticals LP | 1 | $119 |
| PFIZER INC. | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Valinor Pharma, LLC | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $17 |
Products named: PROCLAIM, Evoke, BREZTRI, NURTEC ODT, RELISTOR, MOVANTIK, Belbuca, VYEPTI.
Industry payments across TX — which companies pay providers there.
